The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells
Open accessAbstract
In an inducible oncogenesis model, the miR-200 family is inhibited during CSC formation but not transformation, and inhibition of miR-200b increases CSC formation. Interestingly, miR-200b directly targets Suz12, a subunit of a polycomb repressor complex (PRC2). Loss of miR-200 during CSC formation increases Suz12 expression, Suz12 binding, H3-K27 trimethylation, and Polycomb-mediated repression of the E-cadherin gene. miR-200b expression or Suz12 depletion blocks the formation and maintenance of mammospheres, and in combination with chemotherapy suppresses tumor growth and prolongs remission in mouse xenografts. Conversely, ectopic expression of Suz12 in transformed cells is sufficient to generate CSCs. The miR-200b-Suz12-cadherin pathway is important for CSC growth and invasive ability in genetically distinct breast cancer cells, and its transcriptional signature is observed in metastatic breast tumors. The interaction between miR-200 and Suz12 is highly conserved, suggesting that it represents an ancient regulatory mechanism to control the growth and function of stem cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical responses have also been reported in a small number of patients with SMARCB1-mutant tumours 164 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,568
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R., Chevalier, B. S., Johnstone, S. E., Cole, M. F., Isono, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,296
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,906
Flagged first, then by citations
1 of the 53 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 400
Li, Y., Taketo, T., & Lau, Y. C. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-436-0_1 · Cited by 12
Epigenetic Networks and miRNAs in Stem Cells and Cancer
Zahnow, C. A., & Baylin, S. B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.036 · Cited by 12
Polycomb repressive complex 2 (PRC2) pathway’s role in cancer cell plasticity and drug resistance
Goleij, P., Heidari, M. M., Tabari, M. A. K., Hadipour, M., Rezaee, A., Javan, A., Sanaye, P. M., Larsen, D. S., Daglia, M., & Khan, H. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01563-8 · Cited by 13
Decoding the Epigenome of Breast Cancer
Cortellesi, E., Savini, I., Veneziano, M., Gambacurta, A., Catani, M. V., & Gasperi, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062605 · Cited by 11
Zhang, J., Shao, N., Yang, X., Xie, C., Shi, Y., & Lin, Y. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820979672 · Cited by 11
Pathania, A. S. (2023) · Cancers · doi:10.3390/cancers15102833 · Cited by 13
Emerging Evidence for MicroRNAs as Regulators of Cancer Stem Cells
Sethi, A., & Sholl, L. M. (2011) · Cancers · doi:10.3390/cancers3043957 · Cited by 11
Riggi, N., Suvà, M.-L., & Stamenkovic, I. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.235 · Cited by 11
Epigenetic Reprogramming in Cancer
Lindroth, A. M., Park, Y. J., & Plass, C. (2014) · Epigenetics and human health · doi:10.1007/978-3-642-31974-7_9 · Cited by 12
DNA‐Templated Gold Nanoclusters for miRNA Diagnostics with Branched Hybridization Chain Reaction
Chai, H., Zhu, Y., & Miao, P. (2024) · Small Structures · doi:10.1002/sstr.202400468 · Cited by 10
San, K., Horita, M. A., Ganapathy, A. K., Chinnadurai, G., & Ezekiel, U. R. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.152 · Cited by 10
Concise review: Cancer cell reprogramming and therapeutic implications
Xiao, X., Chen, H., Yang, L., Xie, G., Shimuzu, R., & Murai, A. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101503 · Cited by 10
Panoramic view of microRNAs in regulating cancer stem cells
Zhao, Y., Wei, D., Zhang, Y., & Ji, J. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220007 · Cited by 10
Single-cell RNA sequencing identifies CXADR as a fate determinant of the placental exchange surface
Angelova, D. M., Tsolova, A. O., Prater, M., Ballasy, N., Bacon, W., Hamilton, R. S., Blackwell, D., Yu, Z., Li, X., Liu, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55597-w · Cited by 9
Suppressor of Zeste 12 homolog RNA interference inhibits retinoblastoma cell invasion
Zhou, M., SUN, J., LIU, Y., & Ma, J. (2014) · Oncology Letters · doi:10.3892/ol.2014.2462 · Cited by 9
Chen, C., Hsieh, T., Huang, C., Yu, A., Chang, W.-L., & Shyr, C. (2016) · PubMed Central · Cited by 9
Yu, F., Liu, Q., Liu, Y., Liu, J., & Song, E. (2011) · InTech eBooks · doi:10.5772/22006 · Cited by 8
Ovarian Cancer Recurrence: Role of Ovarian Stem Cells and Epithelial-to-Mesenchymal Transition
F, D. G. G. (2014) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000284 · Cited by 8
Pharmacological Advancements of PRC2 in Cancer Therapy: A Narrative Review
Wang, M. S., Sussman, J., Xu, J.-J., Patel, R. T., Elghawy, O., & Rawla, P. (2024) · Life · doi:10.3390/life14121645 · Cited by 7
Epigenetic changes induced by pathogenic Chlamydia spp
Stein, R. A., & Thompson, L. M. (2023) · Pathogens and Disease · doi:10.1093/femspd/ftad034 · Cited by 10
SUZ12 participates in the proliferation of PNH clones by regulating histone H3K27me3 levels
Chen, Y., Liu, H., Zeng, L., Li, L., Lu, D., Liu, Z., & Fu, R. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a1021-564r · Cited by 7
Breast cancer stem cells programs: enter the (non)-code
Salvador, M. A., Birnbaum, D., Charafe‐Jauffret, E., & Ginestier, C. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw003 · Cited by 7
Jiang, X., Hou, D., Wei, Z., Zheng, S., Zhang, Y., & Li, J. (2019) · ExRNA · doi:10.1186/s41544-019-0014-0 · Cited by 6
Molecular therapies delaying cardiovascular aging: disease- or health-oriented approaches
Magenta, A., Lorde, R., Syed, S. B., Capogrossi, M. C., Puca, A. A., & Madeddu, P. R. (2020) · Vascular Biology · doi:10.1530/vb-19-0029 · Cited by 6
The linkage between microRNA and cancer and its delivery as cancer therapy: A mini-review
Najmuddin, S. U. F. S., Kamarudin, A. A., Sani, S. A., Norrrahim, M. N. F., Latif, N. '. A., & Goh, L. P. W. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.7.2 · Cited by 6
Möllerström, E., Rydenhag, B., Andersson, D., Lebkuechner, I., Puschmann, T. B., Chen, M., Wilhelmsson, U., Ståhlberg, A., Malmgren, K., & Pekny, M. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1431-y · Cited by 6
Khales, S. A., Forghanifard, M. M., Abbaszadegan, M. R., & Hosseini, S. E. (2022) · Advances in Medical Sciences · doi:10.1016/j.advms.2022.11.002 · Cited by 6
Genetic Impairments of PRC2 Activity in Oncology: Problems and Prospects
Chetverina, D., Ломаев, Д. В., Georgiev, P. G., & Erokhin, M. (2021) · Russian Journal of Genetics · doi:10.1134/s1022795421030042 · Cited by 5
Oxidative Stress in Carcinogenesis and Therapy
Hatem, E., & Azzi, S. (2016) · Journal of Cell Signaling · doi:10.4172/2576-1471.1000102 · Cited by 5
MicroRNAs in liver malignancies. Basic science applied in surgery.
Muresan, M. A., Zaharie, F. V., Bojan, A. S., Frinc, I., Dima, D. M., Selicean, S. E., Gafencu, G., Petrushev, B., Cojocneanu, R., Tefas, C., et al. (2015) · PubMed · Cited by 5
MicroRNAs shaping cellular reprogramming
Chakraborty, S., & Ghosh, Z. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815669-8.00004-x · Cited by 5
Ávila‐González, D., Portillo, W., Barragán-Álvarez, C. P., Hernández‐Montes, G., Flores-Garza, E., Molina‐Hernández, A., Diaz-Martinez, N. E., & Díaz, N. F. (2022) · eLife · doi:10.7554/elife.68035 · Cited by 4
microRNA in the control of stem-like phenotype of cancer cells
Woźniak, M. (2013) · Open Life Sciences · doi:10.2478/s11535-013-0222-9 · Cited by 4
Manna, A., Banerjee, S., Khan, P., Bhattacharya, A., & Das, T. (2017) · The Nucleus · doi:10.1007/s13237-017-0193-8 · Cited by 4
Research progress on cancer-related epigenetic switches
Yu, C., Sun, J., Tong, J., Xu, Z., & Zhang, Q. (2025) · Investigational New Drugs · doi:10.1007/s10637-025-01555-2 · Cited by 3
Cancer Stem Cells and Chemoresistance: Strategies to Overcome Therapeutic Resistance
Thomas, M. L., Coyle, K. M., Sultan, M., & Marcato, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-21030-8_17 · Cited by 4
Emerging patterns and implications of breast cancer epigenetics
Venkatesh, T., Thankachan, S., Kabekkodu, S. P., Chakraborti, S., & Suresh, P. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819753-0.00015-5 · Cited by 3
Cell Shape and Cell Lineage Conversion
Nakaya, Y., & Sheng, G. (2014) · The Journal of Poultry Science · doi:10.2141/jpsa.0140088 · Cited by 3
MicroRNAs in Endothelial Development and Differentiation
Yang, Y. Z. F. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000191 · Cited by 3
The role of microRNAs in the formation of cancer stem cells: Future directions for miRNAs
Qian, J., Siragam, V., Lin, J., Ma, J., & Deng, Z. (2011) · Hypothesis · doi:10.5779/hypothesis.v9i1.224 · Cited by 2
Watson, K. L. M., & Moorehead, R. A. (2024) · International Journal of Cancer · doi:10.1002/ijc.35211 · Cited by 2
Epithelial-Mesenchymal Transition and Cancer Stem Cells
Ouyang, G. (2011) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/19282 · Cited by 2
WITHDRAWN: MiR-200 family and cancer: Function, regulation and signaling
Chen, Y., & Zhang, L. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2014.03.001 · Cited by 2
A Glance into Cancer Stem Cells
Khodayari, H., Chamani, R., Khodayari, S., & Alizadeh, A. M. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Crosstalk of proteins, miRNAs involved in metastatic and epithelial–mesenchymal transition pathways
Mishra, S., Tripathi, R., & Singh, S. (2016) · Frontiers in Life Science · doi:10.1080/21553769.2016.1256843 · Cited by 2
Zhang, M., & Rosen, J. M. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200005 · Cited by 2
Role of MiRNAs and It’s Single Nucleotide Polymorphism in Breast CancerPreprint
Roy, D., Bandla, R., Boddana, P., Medisetty, R., & Gogada, R. (2021) · Preprints.org · doi:10.20944/preprints202110.0349.v1 · Cited by 1
Breast cancer invasion by microRNAs aidPreprint
Bedi, A. (2023) · doi:10.22541/au.170000970.06816647/v1 · Cited by 2
Janivarad, T., Kumbar, V. M., Marakatti, R., Kotabagi, S., Kambi, M. I., Lolsure, K., & Paranjape, R. (2026) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2026.106562 · Cited by 1
Primary ciliogenesis is promoted during epithelial-mesenchymal transition via a miR-200 – DZIP1 axis
Sourdin, L., Bracken, J. M., Pillman, K. A., Bert, A. G., Khew‐Goodall, Y., Gregory, P. A., Goodall, G. J., & Bracken, C. P. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02838-8 · Cited by 1
Srivastava, A., Tyagi, N., Mubashra, Shukla, A., & Srivastava, S. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189594 · Cited by 1
Novel Targeted Therapies for Patients with Ovarian Cancer
Farghaly, S. A. (2014) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000e133 · Cited by 1
Eades, G. L., Yao, Y., & Zhou, Q. Y. (2013) · CRC Press eBooks · doi:10.1201/b14586-2 · Cited by 1
Epigenetic regulation and microRNA expression
Jurj, A. M., Zănoagă, O., Braicu, C., & Berindan‐Neagoe, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00003-0 · Cited by 1
Role of noncoding RNA as a pacemaker in cancer stem cell regulation: a review article
Attia, Y. M., Tadros, S. A., Fahim, S. A., & Badr, D. M. (2025) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-025-00266-2 · Cited by 1
Leva, G. D., & Garofalo, M. (2014) · Springer eBooks · doi:10.1007/978-3-319-03725-7_5 · Cited by 1
Tumor Niche Disruption and Metastasis: The Role of Epithelial-Mesenchymal Transition (EMT)
Zilhão, R., & Neves, H. (2019) · Learning materials in biosciences · doi:10.1007/978-3-030-11812-9_9 · Cited by 2
Rola plastyczności komórkowej w procesie powstawania przerzutów nowotworowych.
Bajdak-Rusinek, K. (2021) · Postępy Biochemii · doi:10.18388/pb.2021_378 · Cited by 1
Crosstalk between microRNAs and Epigenetics: From the Nutritional Perspective
Liu, Z., Tammen, S. A., Friso, S., & Choi, S. (2013) · Wiley eBooks · doi:10.1002/9781118695999.ch20 · Cited by 1
Song, C., Wang, J., Wang, H., Liu, P., Liu, L., Yang, L., Tang, H., & Xie, X. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/130682 · Cited by 1
Gallardo, A., Molina, A., Asenjo, H. G., López-Onieva, L., Álvarez-Pérez, J. C., Martorell‐Marugán, J., Cara, F. E., Espinosa-Martínez, M., Carmona‐Sáez, P., Granados-Principal, S. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.11.483977 · Cited by 1
Dissecting the Molecular Mechanism of RhoC GTPase Expression in the Normal and Malignant Breast
Brenner, J. C. (2011) · Defense Technical Information Center (DTIC) · doi:10.21236/ada562247
miRNAs in Cancer Invasion and Metastasis
Humphries, B. A., & Yang, C. (2013) · Wiley eBooks · doi:10.1002/9781118695999.ch8
MicroRNA Regulation of Cancer Stem Cells and MicroRNAs as Potential Cancer Stem Cell Therapeutics
Liu, C., & Tang, D. G. (2013) · doi:10.1002/9781118300312.ch38
The functional microRNA landscape of mammalian development
Ravi, A. (2011)
The Potential Role of MicroRNA-Based Therapy for Lung Cancer Stem Cells
Fujita, Y., Kuwano, K., & Ochiya, T. (2014) · Springer eBooks · doi:10.1007/978-3-319-05134-5_4
Batista, L., & Mechta‐Grigoriou, F. (2013) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/51423
Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences
Drasin, D., Robin, T. P., & Ford, H. L. (2011)
Quantitative Approaches to the Cancer Stem Cell Hypothesis
Tonekaboni, M., & Ali‐Seyed, M. (2015) · UWSpace (University of Waterloo)
A regulatory network of Mdm2 and members of the Polycomb Group (PcG) family
Wienken, M. M. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5475
Epigenetic Regulation of EZH2 and Its Targeted MicroRNAs
Au, S. L., Ng, I. O., & Wong, C. (2013) · Springer eBooks · doi:10.1007/978-94-007-6612-9_3
Altered Chromatin Signaling in Cancer
Liss, A. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802389-1.00018-6
Signaling and Chromatin Networks in Cancer Biology
Heßmann, E., Urrutia, R. A., & König, A. O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802389-1.00013-7
Carcinomes ovariens : l’expression des miR-200 induit stress, prolifération et chimiosensibilisation
Bénard, J. (2012) · Bulletin du Cancer · doi:10.1684/bdc.2012.1542
Epigenetics and precision medicine in bone and soft tissue sarcomas
Fatema, K., Luelling, S., Kirkham, M., Pavek, A., Heyneman, A. L., & Barrott, J. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823008-4.00009-3
神田, 昌. (2005) · 文蔵
Epigenetic Signatures of Breast Cancer Genes
Anant, S., Dhar, A., & Ramalingam, S. (2013) · Springer eBooks · doi:10.1007/978-94-007-6612-9_10
Micro RNA the Important Biomarker in Cancer
Jasim, H. S. (2022) · SAR Journal of Medical Biochemistry · doi:10.36346/sarjmb.2022.v03i02.002
Bushnell, G. G., Brooks, M. D., & Wicha, M. S. (2022) · Holland‐Frei Cancer Medicine · doi:10.1002/9781119000822.hfcm012.pub2
Zheng, T., Zhou, X.-H., Zheng, S.-S., Chen, H., Li, J., Cai, C., Xia, L., & Xue, T. (2023) · Research Square · doi:10.21203/rs.3.rs-2443039/v1
Unveiling the Role of MicroRNAs in Breast Cancer InvasionPreprint
Ahluwalia, K. (2023) · doi:10.22541/au.170000970.04000451/v1
Function of noncoding RNA in regulating cancer cell plasticity
Her, P. H., Lam, M., Zeng, S., & He, H. H. (2024) · Cancer Heterogeneity and Plasticity · doi:10.47248/chp2401020007
Liu, H., Zeng, L., Wang, C., Chen, Y., Li, L., Liu, Z., Wang, H., & Fu, R. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70597
Xu, Y., Wang, J., Gao, Y., Li, J., Ma, Y., Sun, C., Tian, Z., Dong, J., Li, P., & Lv, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148791
Li, W., Cao, Y., Chen, Y., Che, B., He, M., Li, D., Jiang, L., & Ma, L. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1673303
Genomic landscapes and therapeutic perspectives of cancer stem cells in the tumor microenvironment
Shrestha, P., Lee, D., Giri, A., Thi, T.-H. L., & Yook, S. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00794-y · Cited by 2
Influence de la Transition Epithélio-Mésenchymateuse sur la réponse T cytotoxique anti-tumorale
Akalay, I. (2013) · theses.fr (ABES) · doi:10.70675/cb446c70z6112z416ez9557z9831373b9e40
Salvador, M. A. (2014) · theses.fr (ABES) · doi:10.70675/e6271213z23d6z45e2z8558z016ac2e02ef3
GNAS et empreinte parentale : Caractérisation des GNAS-miRNAs et d’une nouvelle DMR
Hanna, P. (2018) · theses.fr (ABES) · doi:10.70675/f26357c5za41ez4af0zae5cz15644b8246db
Développement d’un système rapporteur de la plasticité des cellules cancéreuses du sein
Bidan, N. (2019) · theses.fr (ABES) · doi:10.70675/d709ae78ze281z45a7z9603z09cd3ad008c7
Long, F. N. V. (2019) · theses.fr (ABES) · doi:10.70675/12a8367cz6b6bz4592zbd98zf68b8cd5151d
Epigenetic characterization of cellular pliancy in breast cancer
Benhassoun, R. (2024) · theses.fr (ABES) · doi:10.70675/0b1d39b2za3d7z4b26zb4b0zaafa77d5068a
Amiri, M. N., Mamaghani, M. P., Aghaee‐Bakhtiari, S. H., Bahreyni-Toossi, M.-T., & Azimian, H. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2025.102024
Molecular biology of microRNA-515 during tumor progression
Moghbeli, M., & Attar, M. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100209
Altered chromatin signaling in cancer
Okuda, Y., & Liss, A. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-19001-8.00024-6
The Biological Roles of MicroRNAs in Cancer Stem Cells
Bao, B., Azmi, A. S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., Ali, S. S., & Sarkar, F. H. (2014) · Springer eBooks · doi:10.1007/978-3-319-03725-7_12
Metadata
- Authors
- Iliopoulos, D., Lindahl-Allen, M., Polytarchou, C., Hirsch, H. A., Tsichlis, P. N., & Struhl, K.
- Affiliations
- Harvard University (US)
- Tufts Medical Center (US)
- Corresponding author
- Struhl, Kevin
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 39
- Issue
- 5
- Pages
- 761-772
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC2938080
- OpenAlex
- W2050306367
- Cited by
- 399
- References
- 53
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 10 · 2022: 11 · 2021: 14 · 2020: 21 · 2019: 29 · 2018: 16 · 2017: 24 · 2016: 23 · 2015: 34 · 2014: 51 · 2013: 52 · 2012: 41
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- China Scholarship Council
- National Cancer Institute (R01CA107486, CA 57486, CA107486, R01CA057436)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- miR-200b, SUZ12, cancer stem cells, polycomb repressive complex 2, H3K27me3, E-cadherin, breast cancer, mammospheres, chemoresistance, metastasis, microRNA target regulation
- MeSH terms
- Animals, Breast Neoplasms, Carrier Proteins, Female, Humans, Mice, Nude, Neoplasm Proteins, Neoplasm Transplantation, Nuclear Proteins, Repressor Proteins, RNA, Neoplasm, Transcription Factors, Transplantation, Heterologous, Neoplastic Stem Cells, Cadherins, MicroRNAs, Cell Line, Tumor, Mice, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review